Clinical Trial Update: Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating leflunomide plus low-dose corticosteroid in IgA nephropathy with renal insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Iga Nephropathy

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: Glomerulonephritis, IGA, Renal Insufficiency, Chronic | Phase 4 | Status: UNKNOWN